Rapid establishment of long term culture-initiating cells (LTC-IC) of donor origin after nonmyeloablative allogeneic hematopoietic stem cell transplantation (NST) and significant prognostic impact of donor T cell chimerism on stable engraftment and progression free survival.

被引：0
|
作者：
Keil, F
Prinz, E
Kalhs, P
Mannhalter, C
Nina, W
Greinix, H
机构：
[1] Univ Vienna, Dept Internal Med 1, A-1010 Vienna, Austria
[2] Univ Vienna, Clin Inst Med & Chem Lab Diagnost, A-1010 Vienna, Austria
[3] Univ Vienna, Dept Transfus Med, A-1010 Vienna, Austria
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1588
引用
收藏
页码：409A / 409A
页数：1
相关论文
共 17 条
  • [1] Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival
    Keil, F
    Prinz, E
    Moser, K
    Mannhalter, C
    Kalhs, P
    Worel, N
    Rabitsch, W
    Schulenburg, A
    Mitterbauer, M
    Greinix, H
    TRANSPLANTATION, 2003, 76 (01) : 230 - 236
  • [2] Kinetic of CD3, CD33, CD34 positive donor cells and LTC-IC after non-myeloablative stem cell transplantation:: significant prognostic impact of donor T-cell chimerism on disease free survival and suppression of LTC-IC after non-myeloablative conditioning
    Keil, F
    Prinz, E
    Moser, K
    Kalhs, P
    Mannhalter, C
    Höcker, P
    Worel, N
    Lechner, K
    Greinix, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S154 - S154
  • [3] Engraftment of donor cells after allogeneic stem cell transplantation: comparison and impact of chimerism in whole blood and peripheral CD3+T-cells
    Le Bris, Y.
    Berger, F.
    Menard, A.
    Guillaume, T.
    Peterlin, P.
    Garnier, A.
    Lode, L.
    Moreau, P.
    Bene, M. C.
    Chevallier, P.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S21 - S21
  • [4] Engraftment of Donor Cells after Allogeneic Stem Cell Transplantation: Comparison and Impact of Chimerism in Whole Blood and Peripheral CD3+T-Cells
    Le Bris, Yannick
    Florian, Berger
    Menard, Audrey
    Guillaume, Thierry
    Peterlin, Pierre
    Garnier, Alice
    Lode, Laurence
    Aubert, Laetitia
    Boursier, Marie C.
    Chenais, Veronique
    Perrault, Fabienne
    Sebie, Amandine
    Moreau, Philippe
    Bene, Marie C.
    Chevallier, Patrice
    BLOOD, 2016, 128 (22)
  • [5] Early Mixed T-Cell Chimerism After Allogeneic Hematopoietic Stem Cells Transplantation Is Highly Predictive For Progression Free Survival
    Cornillon, Jerome
    Absi, Lena
    Bourmaud, Aurelie
    Srour, Micha
    Tinquaut, Fabien
    Tavernier, Emmanuelle
    Guyotat, Denis
    BLOOD, 2013, 122 (21)
  • [6] Long-term engraftment and clonal dominance of donor-derived del(20q) hematopoietic cells after allogeneic stem cell transplantation
    Mielcarek, M
    Bryant, E
    Loken, M
    Zaucha, JM
    Torok-Storb, B
    Storb, R
    BLOOD, 2006, 107 (04) : 1732 - 1733
  • [7] Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation—A systematic review and meta-analysis
    Yarui Huang
    Chengxin Luo
    Guixian Wu
    Xiangtao Huang
    Yaqun Ding
    Zhen Huang
    Jieping Chen
    Xi Li
    Shuangnian Xu
    Bone Marrow Transplantation, 2023, 58 : 544 - 551
  • [8] Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation-A systematic review and meta-analysis
    Huang, Yarui
    Luo, Chengxin
    Wu, Guixian
    Huang, Xiangtao
    Ding, Yaqun
    Huang, Zhen
    Chen, Jieping
    Li, Xi
    Xu, Shuangnian
    BONE MARROW TRANSPLANTATION, 2023, 58 (05) : 544 - 551
  • [9] Development of late over early full donor chimerism (FDC) results in improved progression-free and overall survival in patients with advanced malignant lymphomas receiving nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT).
    Ting, DT
    Dey, B
    Chaudhary, A
    Colby, C
    Power, K
    McAfee, S
    Ballen, K
    Attar, E
    Saidman, S
    Preffer, F
    Sackstein, R
    Shaffer, J
    Sykes, M
    Spitzer, TR
    BLOOD, 2005, 106 (11) : 1020A - 1020A
  • [10] Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival
    Shawn Kothari
    Andrew S. Artz
    Sang Mee Lee
    Noreen Fulton
    Jae-Hyun Park
    Wendy Stock
    Richard A. Larson
    Olatoyosi Odenike
    Justin Kline
    James LaBelle
    Satyajit Kosuri
    Peter Riedell
    Yusuke Nakamura
    Michael R. Bishop
    Hongtao Liu
    Bone Marrow Transplantation, 2020, 55 : 1161 - 1168
12